Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN

Vuk Stambolic(Ontario Institute for Cancer Research), Akira Suzuki(Ontario Institute for Cancer Research), José Luís de la Pompa(Ontario Institute for Cancer Research), Greg M. Brothers(Ontario Institute for Cancer Research), Christine Mirtsos(Ontario Institute for Cancer Research), Takehiko Sasaki(Ontario Institute for Cancer Research), Jürgen Ruland(Ontario Institute for Cancer Research), Josef Penninger(Ontario Institute for Cancer Research), David P. Siderovski(Ontario Institute for Cancer Research), Tak W. Mak(Ontario Institute for Cancer Research)
Cell
October 1, 1998
10.1016/s0092-8674(00)81780-8
Cited by 2,552Open Access
Full Text

Abstract

Related Papers

Mechanism of activation of protein kinase B by insulin and IGF‐1.
Dario R. Alessi, Mirjana Andjelković, B. Caudwell et al.|The EMBO Journal|1996|3k
Dual Role of Phosphatidylinositol-3,4,5-trisphosphate in the Activation of Protein Kinase B
David Stokoe, Leonard R. Stephens, Terry Copeland et al.|Science|1997|1.2k
Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt
George Kulik, Anke Klippel, Michael J. Weber|Molecular and Cellular Biology|1997|1.1k
TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
Dongmei Li, Hong Sun|PubMed|1997|875
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Michael P. Myers, Javor P. Stolarov, Charis Eng et al.|Proceedings of the National Academy of Sciences|1997|783